LSE:AZNPharmaceuticals
AstraZeneca FDA Wins Test R&D Execution Across Respiratory Immunology And Oncology
AstraZeneca (LSE:AZN) received US FDA approval for Breztri Aerosphere as a triple-combination inhaler for asthma.
The FDA also approved self-administration of Saphnelo (anifrolumab) via autoinjector for lupus.
The FDA's Oncologic Drugs Advisory Committee issued a positive recommendation for Truqap (capivasertib) for PTEN-deficient hormone-sensitive metastatic prostate cancer.
AstraZeneca is participating in TRAVERSE, the first proof-of-concept real-time clinical trial program in partnership...